Denmark – Novo Nordisk has announced a new partnership to establish human insulin production in South Africa as part of an expanded commitment to provide life-saving treatment to people living with diabetes across the African continent. Novo Nordisk is reaching more than 500,000 people with diabetes across Sub-Saharan Africa. The new partnership will enable production of human insulin for the …
Denmark– Novo Nordisk today announced that the company has agreed to acquire three fill-finish sites from Novo Holdings A/S (Novo Holdings) in connection with a transaction where Novo Holdings has agreed to acquire Catalent, Inc. (Catalent), a global contract development and manufacturing organisation headquartered in Somerset, New Jersey (US). Novo Nordisk and Catalent have a long-standing collaboration. The acquisition of …
Australia – People who put on a lot of weight try to find ways to shed those pounds and take any drastic step to do so. A woman in Australia lost life after Ozempic has become a thing on social media as people are taking the drug after it was rumoured that influencers and celebrities were taking it to control …
Denmark – Novo Nordisk today announced the decision to stop the kidney outcomes trial FLOW (Effect of semaglutide versus placebo on the progression of renal impairment in people with type 2 diabetes and chronic kidney disease). The decision to stop the trial is based on a recommendation from the independent Data Monitoring Committee (DMC) concluding that the results from an …
London – Researchers say weight loss medicines Ozempic and Wegovy by Novo Nordisk, may allow obese people get amazing results but they are not safe. These weight loss medicines carry lean mass that includes an individual’s bones, organs, and muscle — more than actual fat which can prove to be troublesome for one’s body.
